drugset / Trial / NCT01529346

Efficacy Of PF-05089771 In Treating Postoperative Dental Pain

NCT01529346

Phase 2 Completed 235 enrolled Pfizer
RandomizedParallel-groupDouble-blindTreatment

Summary

The objective of this study is to evaluate the overall pain relief of a single dose of PF-05089771 against placebo following third molar extraction.

Timeline

Start
2011-12-12
Primary completion
2012-06-25
Completion
2012-06-25

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ibuprofen Small molecule 400 mg Oral
Subject PF-05089771 Small molecule 150 mg Oral
Subject PF-05089771 Small molecule 450 mg Oral
Subject PF-05089771 Small molecule 1600 mg Oral

Indications

No indication recorded.